Khaitan & Co Advises Temasek Entities On Pine Labs’ DRHP filing For proposed IPO
Khaitan & Co advised Temasek entities Aranda Investments and Macritchie Investments on Pine Labs’ DRHP filing for its INR 26,000 million IPO following its reverse flip to India.
Khaitan & Co Advises Temasek Entities On Pine Labs’ DRHP filing For proposed IPO
Khaitan & Co advised Aranda Investments Pte. Ltd. and Macritchie Investments Pte. Ltd., Temasek-affiliated entities, on corporate and IPO-related aspects in connection with the filing of the draft red herring prospectus (DRHP) by Pine Labs Limited for its proposed initial public offering. The IPO comprises a fresh issue aggregating to INR 26,000 million and an offer for sale of equity shares by certain shareholders.
This IPO filing follows the successful reverse flip of Pine Labs to India, marking a key milestone in its strategic corporate realignment and public markets journey. Khaitan & Co advised the Temasek entities on legal structuring, shareholder documentation, IPO compliance, and regulatory aspects of the transaction.
The Khaitan & Co team was led by Vineet Shingal (Partner, Corporate) and Chirayu Chandani (Partner, Capital Markets), with support from Hrithik Khurana (Senior Associate, Capital Markets) and Vivek Badkur (Associate, Corporate).
Click to know more about Khaitan & Co
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.